Early-stage Vascular Insights LLC isn't saying much yet about its minimally invasive technology for varicose veins, other than it is designed to trigger spasms in the endothelium of the diseased vein in conjunction with the delivery of a sclerosant, a chemical irritant that will further disrupt the vessel wall. This one-two punch will cause veins to stenose very rapidly without risk to surrounding tissues, the company claims, enabling a fast, pain-free procedure in an outpatient setting.
VeinRx Inc. 's balloon-controlled venous ablation technology is designed to address both the medical and cosmetic varicose vein markets....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?